XSHE
300387
Market cap320mUSD
Oct 09, Last price
7.54CNY
1D
1.48%
1Q
7.87%
Jan 2017
-51.35%
IPO
-7.94%
Name
Hubei Forbon Technology Co Ltd
Chart & performance
P/E
36.79
P/S
1.58
EPS
0.20
Div yield, %
0.94%
Shrs. gr., 5y
1.00%
Rev. gr., 5y
15.13%
Revenues
1.38b
+11.87%
Net income
59m
-36.71%
CFO
38m
-74.28%
Dividend
Jun 01, 20260.06 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Hubei Forbon Technology Co.,Ltd. researches, develops, produces, and sells fertilizer additives in China and internationally. The company provides agrochemical adjuvants, such as fertilizer amendment fertilizer, anti-caking agent, and fertilizer coating agent, and energy saving and consumption reduction series products; and crop nutrition products, including soil testing and fertilizer formulations, value-added potash and nitrogen fertilizers, micronutrient fertilizers, soil conditioners, bio-fertilizers, biostimulants, oxygen-eating fertilizers, ammonium sulfate series, and special fertilizer series. It also offers biological control products comprising microbial agents, bactericide, and insecticides. Hubei Forbon Technology Co.,Ltd. was founded in 2000 and is headquartered in Wuhan, China.
Key people
Renzong Wang
Chairman of the Board, General Manager · since 2015
Gang Wan
Finance Director, Deputy General Manager · since 2023
Erik Bijpost
Deputy General Manager · since 2021
Jiawei Feng
Deputy General Manager · since 2015
Yu Liu
Deputy General Manager · since 2023
Zhibin Zhou
Deputy General Manager · since 2019
Min Yi
Deputy General Manager, Secretary of the Board · since 2023
Jiye Mao
Director · since 2019
Gongwu Song
Director · since 2015
Yingzong Wang
Director · since 2023
Director · since 2025
Fei Guo
Independent Director · since 2025
Qiaoyun Huang
Independent Director · since 2023
Zhibiao Ye
Independent Director · since 2023
Jingzhong Yu
Independent Director · since 2019
Headquarters & legal address
湖北省应城市经济技术开发区
孝感市, HB 432000
CN
孝感市, HB 432000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||